{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:24:10Z","timestamp":1782793450619,"version":"3.54.5"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-022-01438-2","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T05:02:52Z","timestamp":1665205372000},"page":"829-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-851X","authenticated-orcid":false,"given":"Marwa","family":"Chbihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurye-Anne","family":"Eveillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Riller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Berthaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Charbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Avramescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Biebuyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Dehoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Garcelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Duong-Van-Huyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"issue":"12","key":"1438_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76(12):1965\u20131973","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/art.34410","volume":"64","author":"L Watson","year":"2012","unstructured":"Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE et al (2012) Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 64(7):2356\u20132365","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","volume":"41","author":"SVB Pinheiro","year":"2019","unstructured":"Pinheiro SVB, Dias RF, Fabiano RCG, Araujo SA, Silva ACS (2019) Pediatric lupus nephritis. J Bras Nefrol 41(2):252\u2013265","journal-title":"J Bras Nefrol"},{"key":"1438_CR4","unstructured":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. - PubMed - NCBI. [cit\u00e9 24 d\u00e9c 2019]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3511372"},{"issue":"8","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, Garrido EER, Danieli MG et al (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46(8):2121\u20132131","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1438_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1191\/096120301682430186","volume":"10","author":"EJ Kingdon","year":"2001","unstructured":"Kingdon EJ, McLean AG, Psimenou E, Davenport A, Powis SH, Sweny P et al (2001) The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus 10(9):606\u2013611","journal-title":"Lupus"},{"key":"1438_CR7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa043731","volume":"353","author":"E Ginzler","year":"2005","unstructured":"Ginzler E, Dooley M, Aranow C, Kim MY, Buyon J, Merrill J et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219\u20132228","journal-title":"N Engl J Med"},{"issue":"3","key":"1438_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.ajkd.2016.12.008","volume":"70","author":"SC Palmer","year":"2017","unstructured":"Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Mavridis D, Tonelli M, Johnson DW et al (2017) Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: a network meta-analysis of randomized trials. Am J Kidney Dis sept 70(3):324\u2013336","journal-title":"Am J Kidney Dis sept"},{"issue":"3","key":"1438_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/acr.21558","volume":"64","author":"R Mina","year":"2012","unstructured":"Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N et al (2012) Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res 64(3):375\u2013383","journal-title":"Arthritis Care Res"},{"issue":"5","key":"1438_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pedhc.2007.07.006","volume":"22","author":"KK Lau","year":"2008","unstructured":"Lau KK, Ault BH, Jones DP, Butani L (2008) Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate Mofetil. J Pediatr Health Care 22(5):282\u2013288","journal-title":"J Pediatr Health Care"},{"key":"1438_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jbi.2018.02.019","volume":"80","author":"N Garcelon","year":"2018","unstructured":"Garcelon N, Neuraz A, Salomon R, Faour H, Benoit V, Delapalme A et al (2018) A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse. J Biomed Inform avr 80:52\u201363","journal-title":"J Biomed Inform avr"},{"issue":"9","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1438_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521\u2013530","journal-title":"Kidney Int"},{"issue":"10","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3899\/jrheum.140050","volume":"41","author":"SY Tian","year":"2014","unstructured":"Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED (2014) Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis. J Rheumatol 41(10):1998\u20132007","journal-title":"J Rheumatol"},{"issue":"5","key":"1438_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D et al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol JASN 20(5):1103\u20131112","journal-title":"J Am Soc Nephrol JASN"},{"key":"1438_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319836712?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J et al (2019) Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus. https:\/\/doi.org\/10.1177\/0961203319836712?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed","journal-title":"Lupus"},{"issue":"6","key":"1438_CR17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/art.40079","volume":"69","author":"F Tamirou","year":"2017","unstructured":"Tamirou F, Husson SN, Gruson D, Debi\u00e8ve F, Lauwerys BR, Houssiau FA (2017) Brief report: The Euro-Lupus low-dose intravenous cyclophosphamide regimen does not impact the ovarian reserve, as measured by serum levels of anti-M\u00fcllerian Hormone. Arthritis Rheumatol Hoboken NJ 69(6):1267\u20131271","journal-title":"Arthritis Rheumatol Hoboken NJ"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01438-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:17Z","timestamp":1777564457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/3\/829\/8307291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01438-2","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose. The authors have no financial relationship relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical committee of Necker-Enfants Malades hospital (APHP general register Number 2020 0805180729).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}